Differential covering and coating methods

Information

  • Patent Grant
  • 7959671
  • Patent Number
    7,959,671
  • Date Filed
    Thursday, November 20, 2003
    21 years ago
  • Date Issued
    Tuesday, June 14, 2011
    13 years ago
Abstract
The present invention, in an exemplary embodiment, provides a stent, which combines many of the excellent characteristics of both silicone and metal stents while eliminating the undesirable ones. In particular, a principal objective in accordance with the present invention is to provide a family of stents where the relative hardness/softness of regions of the stent can differ from other regions of the stent to provide additional patient comfort and resistance to compression forces. Exemplary embodiments provide a stent that is covered so as to provide certain predefined characteristics. In particular, a covered stent is provided that is coated internally such that the outer scaffolding surface of the stent has enhanced friction points while the internal surface exemplifies certain characteristics.
Description
FIELD OF INVENTION

The present invention relates generally to methods of covering and/or coating medical devices and more particularly to methods of manipulating the compliance of the cover to modify fluid mechanics on the interior of the medical device and the friction points on the exterior thereof.


BACKGROUND OF THE INVENTION

Stents are devices that are inserted into a vessel or passage to keep the lumen open and prevent closure due to a stricture, external compression, or internal obstruction. In particular, stents are commonly used to keep blood vessels open in the coronary arteries and they are frequently inserted into the ureters to maintain drainage from the kidneys, the bile duct for pancreatic cancer or cholangiocarcinoma or the esophagus for strictures or cancer. Vascular as well as not vascular stenting has evolved significantly; unfortunately there remain significant limitations with respect to the technology for producing stents suitable to various portions of a patient's anatomy.


Historically, in order to provide a stent with varying characteristics, the stent had to be manufactured from multiple materials, at least one for each characteristic desired. As a result, many of these stents are woven from two or more metals having differing shape-memories for example. Unfortunately, braided stents are vulnerable to premature obsolescence. Moreover, providing multiple material types in a single stent may lead to inconsistent characteristics along the surface area of the stent. This is particularly undesirable when the stent is to be placed in vascular or nonvascular lumens that have been occluded for one reason or another. The stent needs to be stiffer in some regions while more flexible in others.


Additionally, medical device companies have identified the need to cover stents at least partially to prevent the epithelialization of the scaffolding. Most covered stents however have an elastomeric cover that is subject to bunching particularly about stenotic tissue. This can lead to additional tissue granulation. Additionally, the stents are dip coated which can lead to uneven coating as well as inconsistency in stent performance from batch to batch.


Additionally the ends of the stent tend to be exposed in order to encourage granulation tissue formation, which helps to anchor the stent in place. With metal stents, the direct metal to tissue contact accelerates tissue granulation and galvanic current generation is also an undesirable byproduct. Such direct current can have indirect effects on tissue granulation and direct effects on fluid flow dynamics.


Moreover, since many medical device companies have chosen to use poorly adapted cardiovascular stents for Pulmonary, GI and Peripheral Vascular indications, many of the anatomical differences in the lumens are not accounted for in stent design. For example, the pulsation of the cardiovascular lumen and the concomitant radial force requirements of a cardiovascular stent differ substantially from that of a tightly constricted lumen such as the trachea during repeated coughing. When a stent developed for the former is indicated for the latter, the stent tends to fail under the extreme conditions and lose its elasticity and therefore its ability of ensure airway patency. Non-vascular lumens also tend to have ciliated epithelia so as to facilitate clearance of fluids and particulates. As a general principal, coated stents were not specifically designed for ciliated lumen in that the external coating damages the cilia and prevents the body's natural clearing function. Moreover, the coating itself is usually made of a predominately hydrophilic polymer, which can lead to mucous formation and/or fluid stagnation. Stagnation of fluids or material passing through the lumen can lead to additional complications such as in stent restenosis or bacterial infections.


Therefore, there remains an existing need for a therapeutic stent that can have varying characteristics along its surface area while being stamped, not branded, from a single base material. Moreover, there is a need for such a therapeutic stent where the relative hardness, softness, flexibility, stiffness and radial force can be modified as a function of geometric considerations rather than material considerations. In particular, there is a need for a stent that is divided into zones so as to allow the stent to have predetermined characteristics in one zone and could conceivably have drastically different characteristics in an adjacent zone so as to allow for stents that can be tailored to anatomical lumens in general and the particular lumen topography of a specific patient in particular. An additional need exists for a method of differentially modifying the location, compliance, and density of the cover to achieve desired behavior. In particular, there is a need for a covered stent that is preferably covered internally such that the outer scaffolding surface of the stent is raised from the outer surface of the coating. To this end, cilia function is only partially limited and mucociliary clearance is not significantly affected. A need also remains for a coating that itself has anti-adherent properties or is complexed with an anti-adherent such that bacteria, fungi or other microbials cannot colonize the cover in particular and the stent generally. There also remains a need for a cover for the proximal and distal ends of the stent that prevent epithelialization and granulation tissue formation while achieving the benefits of traditional uncovered stents.


SUMMARY OF EXEMPLARY EMBODIMENTS

It is a principal purpose of the present invention to provide a stent, in accordance with an exemplary embodiment of the present invention, which combines many of the excellent characteristics of both silicone and metal stents while eliminating the undesirable ones. In particular, it is an objective of a preferred embodiment in accordance with the present invention to provide a stent that is easily installed, yet in alternative embodiments, removable. Moreover the stent in accordance with this embodiment of the present invention would not cause material infections and may be capable of reducing infection. Therefore, a principal objective of a preferred embodiment in accordance with the present invention is to provide a prosthesis that is suitable for both permanent and temporary use while being easy to insert, reposition and remove.


A principal objective of a preferred embodiment of the present invention is to provide a stent that may be stamped from preferably a single material that is capable of maintaining its axial working length when radially compressed. To this end, the stent does not have a seam that could aggravate luminal tissue. In particular, a stent in accordance with the present invention is formed using a tool that molds the stents outer contour as well as its interstices.


It is yet another objective of an exemplary embodiment of the present invention to provide a stent that can be indicated for the treatment of benign and malignant disease and improve the way clinicians treat malignant obstructions.


Still another objective of the present invention is to provide a stent and method for installing the stent that is economical and suitable for routine purposes. Moreover, the stent will have minimal migration, cause minimal tissue granulation, will not foreshorten after deployment and mucociliary clearance will not be problematic.


Yet another objective of an exemplary embodiment in accordance with the present invention is to provide a prosthesis that will have superior internal to external diameter ratio, superior radial force with dynamic expansion, while being suitable for use in pediatric and adult patients with malignant and benign disease.


A principal objective of an exemplary stent in accordance with the present invention is to provide a family of stents where the relative hardness/softness of regions of the stent can differ from other regions of the stent to provide additional patient comfort and resistance to radial forces.


An additional objective in accordance with an exemplary embodiment is to provide a family of stents with novel interstice configurations that facilitate flexibility, durability and/or proper installation.


Still another objective of a preferred embodiment of the present invention is to provide a self-expanding stent having the above benefits that also defines a plurality of apertures at the termini of the stent or along the scaffolding there between for, inter alia, removal of the stent. In the furtherance of this and other objective, suture may be treaded through one or more of these apertures to facilitate purse string like removal of the device.


An additional objective in accordance with a preferred embodiment of the present invention is to provide a prosthesis that minimizes cilia destruction at the site of implantation. In the furtherance of this and other objectives, the preferred prosthesis is coated internally with a polyurethane such that the surfaces of the struts that come into contact with the lumen of the patient are elevated above the surface of the coating such that the cilia can move to allow for free fluid action of ciliated epithelium.


Still another objective in accordance with the present invention is to provide a cover and method for applying the cover to a stent. The cover may be applied such that the cover is at various levels of compliance with respect to the stent struts. To this end, it provides an opportunity to manipulate flow mechanics for the inner diameter of the stent as well as the friction points of the outer diameter of the stent.


Yet another objective in accordance with the present invention is to provide covering about the distal end, the proximal end or combination so as to retain the benefits of an uncovered stent while retaining the ability to remove the stent. Moreover, the end only and full stent covering may be provided in addition to the coating to eliminate galvanic current.


Further objectives, features and advantages of the invention will be apparent from the following detailed description taken in conjunction with the accompanying drawings.





BRIEF DESCRIPTION OF THE FIGURES


FIG. 1 shows a perspective view of the cross-section of select struts of an exemplary stent with a covering applied to the internal diameter so as to cause the cover to conform to the stent struts.



FIG. 2 shows an alternative perspective view of the select stent strut cross-section of FIG. 1 where the cover is not compliant with the stent struts.



FIG. 3 shows an enlarged perspective view of a stent viewed from one end through the lumen thereof showing the compliant cover of FIG. 1.



FIG. 4 shows an alternative end-to-end perspective view of the stent where the cover is super-compliant in certain regions of the stent such that the cover extends through the interstices toward the outer surface of the stent.



FIG. 5 shows an enlarged perspective view of the struts where the cover does not conform to the geometry of the struts.





DETAILED DESCRIPTION OF AN EMBODIMENT

A preferred embodiment of the stent, in accordance with the present invention, provides a stent that prevents epithelialization of the stent and is not subject to premature elongation and foreshortening but is capable of engaging the desired implantation location. The stent also retains its axial length while undergoing radial compression.


The stent is preferably formed from a composite material selected from the group consisting essentially of Ni, C, Co, Cu, Cr, H, Fe, Nb, O, Ti and combinations thereof. The composite material is generally formed into a compressed tube from which the stent is etched and is formed on a suitable shaping device to give the stent the desired external geometry. Both the synthetic collar techniques and in vitro valuation techniques show the remarkable ability of stents in accordance with the present invention to convert acting force into deformation work absorbed by the angled structure, which prevents excessive scaffolding stress and premature material fatigue and accelerated obsolescence.


Though one skilled in the stent engineering art, once apprised of the present application, would be able to manufacture a stent consistent with the present invention by other methods, a preferred method of manufacturing such stents follows. As stated above a composite material is selected and a blank is formed there from. The blank is preferably laser etched and the etch work is generally verified for accuracy using visual recording microscopy. Dimensional measurements are taken to ensure strut thickness, segment angles, zone placement, etc. Moreover, the stent is preferably formed on a shaping tool that has substantially the desired contour of the external stent dimensions.


In the event the stent is to be shaped to the dimensions of a particular lumen, optical photography and/or optical videography of the target lumen may be conducted prior to stent formation. The geometry of corresponding zones and connector regions of the stent then can be etched and formed in accordance with the requirements of that target lumen. For example, if the stent were designed for the trachea, which has a substantially D shaped lumen and additionally the middle zones needed to be softer than the end zones, the stent could be designed to those specifications. Stent angles may be modified to provide different characteristics to different zones of the stent. In particular, if the topography of the trachea of a particular patient is captured optically and the appropriate dimension provided, a patient specific prosthesis could be engineered. These techniques can be adapted to other non-vascular lumen but is very well suited for vascular applications where patient specific topography is a function of a variety of factors such as genetics, lifestyle, etc.


It should be pointed out that unlike the use of differing shape memory materials to change regions of a stent, stents in accordance with the present invention can take on an infinite number of characteristic combinations as zones and segments within a zone can be modified by changing angles, segment lengths and segment thicknesses during the etching and forming stages of stent engineering or during post formation processing and polishing steps. Moreover, by modifying the geometry of the connectors between zones, additional functionality may be achieved.


Exemplary stents in accordance with the present invention are shown in FIGS. 1-3 showing the preferred interstice geometry. Not shown are a wide variety of interstice geometries that are also acceptable alternatives to the preferred, namely, U, V, W, Z, S and X geometries to name a few.


The stent also is formed of memory metal and preferably has unique geometrical interstices that are laser etched therein. However, other conventional ways of forming interstices in unitary stents, though not equivalent are contemplated, may be employed and would be within the skill set of one in the art.


It cannot be overemphasized, however, that this does not mean the knowledge that changes in the geometry of interstices affect stent functionality is currently known in the art. To the contrary, the present inventors discovered the interrelation between interstice geometry, width, length and relative resistance to torsional stress and radial force. In fact, it can be said that the stent has circumferential bands extending perpendicularly with respect to the luminal device's longitudinal axis. These bands are referred to generally as zones. A connector connects these bands to one another; the connector is an additional means for adjusting stent functionality. In particular, the connector defines a substantially U shaped member, but could define other geometries such as U, V, W, Z, S and X to name a few. Also a plurality of eyelets that allow a physician to purse string the stent with suture to facilitate removability. The eyelets are preferably between about 200 μm and 300 μm, however, the eyelets may be smaller or larger to accommodate the need of the target site. The preferred eyelet size is about 350 μm as the preferred suture type is 4-0. The medical appliance may be pre-threaded with suture or the user may provide the suture after implantation.


An exemplary stent in accordance with the present invention with relatively great torsionality and radial flexibility would be rated soft. An exemplary soft rated stent comprises distance between U shaped connectors of about 4.5 μm in the compressed state (i.e., contracted in the 3 mm tube subject to laser etching). Moreover, the length of the crossing member is preferably about 1.0 μm. The lengths of the leg members are preferably about 1.5 μm long. Additionally the leg members may further comprise feet that attached to the remainder of the stent scaffolding. The feet can be adjusted from a standard length of about 0.25 μm to further adjust the characteristics of the stent. There is additionally a substantially rectangular member incorporated in the U shaped connector with similar capacity for variability. The variability factors and results of modifying the dimensions of the substantially rectangular members are similar to those evinced by leg length dimensional modifications.


By way of example, but not to be construed in any way as limiting, the softness index or relative flexibility can be increase by increasing the various lengths discussed above. For example, by increasing the length of the legs and crossing members of the U shaped connector, flexibility increases. However, with respect to the distance between U shaped members and distance between interstices in a preferred stent embodiment, there is an inverse correlation between length and softness. This relative softness/hardness indexing as a corollary of interstice dimensions is a novel aspect of preferred embodiment of the present invention. As a practical rule of thumb, longer leg lengths coupled with acute angles provide for greater flexibility. Conversely, shorter leg lengths and more obtuse angles provide more rigidity. By way of non-limiting example, a U shaped connector with short legs deviating from the crossing member at angles greater than 90°, will be extremely rigid and resistant to torsional strain as compared to a U shaped connector with longer legs diverging from the crossing member at angles less than 90°.


In addition to the length and spacing differences, the interstices themselves may define various shapes that by their very nature afford novel functionality to the stent. The changes of functionality, however, are more a function of the dimensional differences of the various shapes rather than a function of the shapes themselves. Therefore, it is important to keep in mind that the dimensional differences discussed in the previous paragraph are determinative of the functionality accorded the stent by the varying interstice geometries. It is for this reason that one of ordinary skill in the art, after being apprised of the present invention, would be able to conceive of a number of interstice geometries to satisfy certain functionality criteria by keeping certain dimensional parameters constant.



FIGS. 1-3 also show the coating provided in select embodiments in accordance with the present invention. The coating preferably comprises a stable polymeric material such as polyurethane that can be deposited on a stent to form a thin film. The film preferably forms layers when annealed to the stent such that the hydrophobic moieties within the polymer are predominately oriented outward and the hydrophilic moieties are predominately oriented inward. It should be noted that depending on the characteristics desired by the user, the relative hydroaffinity may be altered. For example, in the event the implant was placed with the intention of collecting mucous in the respiratory system, the coating would more suitably have a predominately hydrophilic outer surface. Moreover, by manipulating the hydroaffinity of the coating, the physiochemical parameters such as surface-free energy, charge density provide a substantial barrier to biofilm formation in general and ligand-binding events mediated by microbial adhesions and extracellular polymers. However, additional anti-adherents know in the art may be applied to provide lubricity as well as an additional barrier for microbials. For example, a preferred coating in accordance with the present invention would be hydrophilic and hydroscope to ensure the surface would always be wet which prevents mucostasis as well as microbial adherence.


Regardless of desired coating surface characteristics, preferred stents in accordance with the present invention are covered from the interior of the stent lumen. In one embodiment, the cover adheres completely to contours of the stent struts. The cover may be strategically applied to either form a strut compliant membrane, a non-compliant membrane within the internal diameter of the stent or incrementally in between. One of the principal functions of the variable covering method is to enhance friction points on the exterior of the stent and/or control flow dynamics through the interior lumen of the stent.


Making specific reference to FIGS. 1 and 3, the stent struts 100 are shown with the interior lumen surface 120 facing upward. When covering the stent struts 100 from the interior surface 140, a compliant cover forms angles between the struts 100 that can cause fluid retention. If this is a desirable characteristic based on the target lumen of the stent, such covering can be achieved by using a compliant heating mechanism when coupling the cover 200 to the struts. Alternatively, as shown in FIGS. 2 and 5, if a relatively smooth interior diameter is desired, the cover 200 would be applied to the struts 100 with a non-compliant device so as to prevent the cover 200 from conforming to the contours of the stent struts 100.


With respect to FIG. 4, there may be instances where the cover 200 needs to be super compliant such that the cover 200, though applied to the inner surface 120 of the stent, the cover extends through the interstices to the outer surface 140. By modifying the cover compliance between these extremes, it is possible to optimize the degree of friction and flow based on desired design metrics.


The stent is preferably coated in a multi-step process, which comprises providing a stent and initially spraying the stent with a polymeric material to coat the struts. Though the steps may be reversed it is preferable to follow the spraying step with the interior coating step. In particular, the stent is placed into a hollow mold to retain the stent shape as the internal diameter of the stent is coated with the polymeric material to form a non-porous cover 200. An alternative cover could be porous for breathability or selective leaching. The cover 100 can be provided in sheets or additional spray applications, however, the preferred embodiment is thin sheets. Sheets are generally preferred to facilitate the proper orientation of the polymer side chains to ensure that the desired moiety (e.g., hydrophilic and/or hydrophobic) is facing the lumen. Once the layer of polymer is introduced into the inner diameter of the stent, an application device such as a balloon or other device in which temperature can be regulated is implanted to sandwich the layer of polymer between the stent inner diameter and the balloon. The balloon is expanded and heated to a temperature of about between 200° and 400° F. to anneal the polymer to the stent. Preferred polymers such as various designer polyurethanes (e.g., Cronoflex® manufactured by Cardiotech International) are suitable for such applications but other polymers are acceptable. Degree of conformity may depend on the compliance of the balloon as well as the presence or absence of a collar about the external surface of the stent. The collar may have ribs complementary to the stent interstices or alternatively recessed wells to facilitate the extent of super compliance of the cover.


Additionally, the same methods may be employed to cover and coat portions of the stent rather than the complete stent. In particular, smaller pieces of covering material may be applied to the distal and proximal ends of the stent to prevent excessive granulation material. Such stents would be valuable in cases such as photodynamic therapy and lung transplants where bare metal stents are generally employed.


The present invention may be embodied in other specific forms without departing from its spirit or essential characteristics. The described embodiments are to be considered in all respects only as illustrative, and not restrictive. The scope of the invention is, therefore, indicated by the appended claims, rather than by the foregoing description. All changes, which come within the meaning and range of equivalency of the claims, are to be embraced within their scope.

Claims
  • 1. A medical appliance for placement within a portion of the anatomy of a patient, the appliance comprising: a scaffolding, the scaffolding configured to define a substantially cylindrical member having a distal end and a proximal end and extending longitudinally there between, forming a lumen there through, along the longitudinal extension of the appliance the scaffolding having an interior and an exterior surface comprising struts with geometrical patterns formed by angles, wherein the angles determine the relative flexibility of the medical appliance such that the appliance conforms to the topography of a target lumen and when pressure is exerted along varying points of the longitudinal extension of the appliance, the appliance does not foreshorten or elongate, wherein the struts comprise an interior and an exterior surface; anda cover, comprising an interior surface and an exterior surface, the exterior surface of the cover adhered to the interior surfaces of a plurality of the struts, such that the interior surfaces of the plurality of struts and the are between the plurality of struts are covered.
  • 2. The medical appliance of claim 1, wherein the cover adheres to the interior surfaces of the struts such that both the interior surfaces of the struts and the area between the struts are covered, the cover having sufficient thickness to prevent galvanic current.
  • 3. The medical appliance of claim 2, wherein a portion of the medical appliance is covered with a polymeric material.
  • 4. The medical appliance of claim 1, wherein only the ends of the medical appliance are covered.
  • 5. The medical appliance of claim 1, wherein the cover is substantially hydrophobic.
  • 6. The medical appliance of claim 5, wherein the cover is hydroscopic.
  • 7. The medical appliance of claim 1, wherein the cover is substantially hydrophilic.
  • 8. The medical appliance of claim 7, wherein the cover is substantially hydroscopic.
  • 9. The medical appliance of claim 1, wherein at least one strut defines an aperture there through.
  • 10. The medical appliance of claim 9, wherein the at least one aperture defines an eyelet of sufficient diameter to receive suture.
  • 11. The medical appliance of claim 10, wherein the eyelet diameter is at least 300 μm.
  • 12. The medical appliance of claim 1, wherein the cover does not inhibit flexing or radial expansion of the medical appliance.
  • 13. The medical appliance of claim 1, wherein the cover adheres completely to contours of the stent struts such that angles are formed between the cover and the struts for fluid retention.
  • 14. The medical appliance of claim 1, wherein the dimensions of the scaffolding geometry determine torsionality of the medical appliance.
  • 15. The medical appliance of claim 1, wherein the scaffolding is formed of a memory capable alloy.
  • 16. The medical appliance of claim 15, wherein the scaffolding is electropolished.
  • 17. The medical appliance of claim 1, wherein along the longitudinal expanse of the scaffolding the medical appliance further comprises a plurality of flanges that define apertures there through.
  • 18. The medical appliance of claim 1, further comprising a connector coupled with portions of the geometrical patterns, the connector comprising a crossing member and a plurality of leg members extending from the crossing member.
  • 19. The medical appliance of claim 18, wherein the connector further comprises a rectangular detent extending from a leg thereof.
  • 20. The medical appliance of claim 19, wherein the angle at which the leg members extend from the crossing member is greater than 90°.
  • 21. The medical appliance of claim 20, wherein the medical appliance is rigid.
  • 22. The medical appliance of claim 21, wherein the medical appliance is flexible.
  • 23. The medical appliance of claim 20, wherein the angle at which the leg members extend from the crossing member is 90° or less.
  • 24. The medical appliance of claim 18, wherein the length of the leg members and the degree of the angle at which the legs extend from the crossing member determines the flexibility of the medical appliance.
  • 25. The medical appliance of claim 1, wherein the cover is non-compliant and the interior surface of the cover is smooth.
  • 26. The medical appliance of claim 1, wherein the cover is compliant and extends through the interstices of the scaffolding toward the outer surface of the scaffolding.
  • 27. A method of covering a medical appliance, comprising the steps of: providing a mold having an internal and an external diameter;providing a medical appliance comprising a scaffolding, the scaffolding configured to define a substantially cylindrical member having a distal end and a proximal end and extending longitudinally there between, forming a lumen there through, along the longitudinal extension of the appliance the scaffolding having an interior and an exterior surface comprising struts with geometrical patterns formed by angles, wherein the angles determine the relative flexibility of the medical appliance such that the appliance conforms to the topography of a target lumen and when pressure is exerted along varying points of the longitudinal extension of the appliance, the appliance does not undesirably foreshorten or elongate, wherein the struts comprise and interior and an exterior surface;inserting the medical appliance into the internal diameter of the mold;applying a compliant cover to the interior surface of the medical appliance; andannealing the cover to the stent by applying heat to the cover such that the cover adheres to the interior surfaces of a plurality of struts, such that the interior surfaces of the plurality of struts and the area between the plurality of struts are covered.
  • 28. The method of claim 27, further comprising the step of applying a polymer to the exterior surface of the scaffolding.
  • 29. The method of claim 27, wherein annealing comprises annealing the cover to the stent using a compliant heating mechanism.
  • 30. The method of claim 27, further comprising positioning a collar around the external surface of the stent prior to annealing the cover to the stent, wherein the collar comprises ribs or wells for facilitating annealing of the cover between the interior and exterior surfaces of the scaffolding.
PRIORITY CLAIM

This patent application is a continuation in part of and claims the benefit of priority under 35 U.S.C. §120 to U.S. Nonprovisional application Ser. No. 10/288,615, filed Nov. 5, 2002 now U.S. Pat. No. 7,527,644, which is incorporated in its entirety by this reference.

US Referenced Citations (455)
Number Name Date Kind
3818511 Goldberg et al. Jun 1974 A
4343048 Ross et al. Aug 1982 A
4441215 Kaster Apr 1984 A
4655771 Wallsten Apr 1987 A
4665906 Jervis May 1987 A
4680031 Alonso Jul 1987 A
4733665 Palmaz Mar 1988 A
4739762 Palmaz Apr 1988 A
4743251 Barra May 1988 A
4800882 Gianturco Jan 1989 A
4820262 Finney Apr 1989 A
4820298 Leveen et al. Apr 1989 A
4856516 Hillstead Aug 1989 A
4886062 Wiktor Dec 1989 A
5032128 Alonso Jul 1991 A
5061275 Wallsten et al. Oct 1991 A
5064435 Porter Nov 1991 A
5067957 Jervis Nov 1991 A
5073694 Tessier et al. Dec 1991 A
5102417 Palmaz Apr 1992 A
5104404 Wolff Apr 1992 A
5190546 Jervis Mar 1993 A
5195984 Schatz Mar 1993 A
5229431 Pinchuk Jul 1993 A
5292331 Boneau Mar 1994 A
5345057 Muller Sep 1994 A
5354309 Schnepp-Pesch et al. Oct 1994 A
5356423 Tihon et al. Oct 1994 A
5364340 Coll Nov 1994 A
5383892 Cardon et al. Jan 1995 A
5383925 Schmitt Jan 1995 A
5421955 Lau et al. Jun 1995 A
5433723 Lindenberg et al. Jul 1995 A
5443498 Fontaine Aug 1995 A
5449373 Pinchasik et al. Sep 1995 A
5480431 Frietag et al. Jan 1996 A
5514154 Lau et al. May 1996 A
5520697 Lindenberg et al. May 1996 A
5534287 Lukic Jul 1996 A
5540713 Schnepp-Pesch et al. Jul 1996 A
5556414 Turi Sep 1996 A
5562725 Schmitt et al. Oct 1996 A
5575818 Pinchuk Nov 1996 A
5591157 Hennings et al. Jan 1997 A
5591197 Orth et al. Jan 1997 A
5593442 Klein Jan 1997 A
5597378 Jervis Jan 1997 A
5601593 Freitag Feb 1997 A
5609629 Fearnot et al. Mar 1997 A
5618301 Hauenstein et al. Apr 1997 A
5628788 Pinchuk May 1997 A
5643312 Fischell et al. Jul 1997 A
5645559 Hachtman et al. Jul 1997 A
5662713 Andersen et al. Sep 1997 A
5667486 Mikulich et al. Sep 1997 A
5674241 Bley et al. Oct 1997 A
5681346 Orth et al. Oct 1997 A
5690644 Yurek et al. Nov 1997 A
5695499 Helgrson et al. Dec 1997 A
5697971 Fischell et al. Dec 1997 A
5702418 Ravenscroft Dec 1997 A
5707386 Schnepp-Pesch et al. Jan 1998 A
5713949 Jayaraman Feb 1998 A
5716393 Lindenberg et al. Feb 1998 A
5725572 Lam et al. Mar 1998 A
5733303 Israel et al. Mar 1998 A
5741333 Frid Apr 1998 A
5755776 Al-Saadon May 1998 A
5755781 Jayaraman May 1998 A
5759192 Saunders Jun 1998 A
5766238 Lau et al. Jun 1998 A
5776161 Globerman Jul 1998 A
5780807 Saunders Jul 1998 A
5807404 Richter Sep 1998 A
5814063 Freitag Sep 1998 A
5824042 Lombardi et al. Oct 1998 A
5827321 Roubin et al. Oct 1998 A
5833707 McIntyre et al. Nov 1998 A
5836966 St. Germain Nov 1998 A
5837313 Ding et al. Nov 1998 A
5843120 Israel et al. Dec 1998 A
5853419 Imran Dec 1998 A
5860999 Schnepp-Pesch et al. Jan 1999 A
5873904 Ragheb et al. Feb 1999 A
5876418 KarlheinzHauenstein et al. Mar 1999 A
5876445 Andersen et al. Mar 1999 A
5876448 Thompson et al. Mar 1999 A
5876449 Starck et al. Mar 1999 A
5879370 Fischell et al. Mar 1999 A
5902475 Trozera et al. May 1999 A
5911732 Hojeibane Jun 1999 A
5922019 Hankh et al. Jul 1999 A
5922020 Klein et al. Jul 1999 A
5922119 Hankh et al. Jul 1999 A
5922393 Jayaraman Jul 1999 A
5931866 Frantzen Aug 1999 A
5935162 Dang Aug 1999 A
5938682 Hojeibane et al. Aug 1999 A
5968070 Bley et al. Oct 1999 A
5968091 Pinchuk et al. Oct 1999 A
5971950 Lopez et al. Oct 1999 A
5972018 Israel et al. Oct 1999 A
5980552 Pinchasik et al. Nov 1999 A
6017365 Von Oepen Jan 2000 A
6019778 Wilson et al. Feb 2000 A
6022371 Killion Feb 2000 A
6027527 Asano et al. Feb 2000 A
6033435 Penn et al. Mar 2000 A
6042597 Kveen et al. Mar 2000 A
6048361 Von Oepen Apr 2000 A
6051021 Frid Apr 2000 A
6053941 Lindenberg et al. Apr 2000 A
6056775 Borghi et al. May 2000 A
6059811 Pinchasik et al. May 2000 A
6096070 Ragheb et al. Aug 2000 A
6099560 Penn et al. Aug 2000 A
6106548 Roubin et al. Aug 2000 A
6120534 Ruiz Sep 2000 A
6131266 Saunders Oct 2000 A
6132461 Thompson Oct 2000 A
6136006 Johnson et al. Oct 2000 A
6136022 Nunez et al. Oct 2000 A
6139573 Sogard et al. Oct 2000 A
6146403 St. Germain Nov 2000 A
6146416 Andersen et al. Nov 2000 A
6156052 Richter et al. Dec 2000 A
6159238 Killion et al. Dec 2000 A
6159239 Greenhalgh Dec 2000 A
6171334 Cox Jan 2001 B1
6174329 Callol et al. Jan 2001 B1
6179867 Cox Jan 2001 B1
6183506 Penn et al. Feb 2001 B1
6190407 Ogle et al. Feb 2001 B1
6193744 Ehr et al. Feb 2001 B1
6203568 Lombardi et al. Mar 2001 B1
6206916 Furst Mar 2001 B1
6217608 Penn et al. Apr 2001 B1
6231598 Berry et al. May 2001 B1
6231599 Ley May 2001 B1
6238430 Klumb et al. May 2001 B1
6241760 Jang Jun 2001 B1
6248058 Silverman et al. Jun 2001 B1
6251134 Alt et al. Jun 2001 B1
6258121 Yang et al. Jul 2001 B1
6270524 Kim Aug 2001 B1
6273910 Limon Aug 2001 B1
6283992 Hankh et al. Sep 2001 B1
6293964 Yadav Sep 2001 B1
6293966 Frantzen Sep 2001 B1
6293968 Taheri Sep 2001 B1
6299622 Snow et al. Oct 2001 B1
6306141 Jervis Oct 2001 B1
6312459 Huang et al. Nov 2001 B1
6315794 Richter Nov 2001 B1
6322586 Monroe et al. Nov 2001 B1
6325821 Gaschino et al. Dec 2001 B1
6325825 Kula et al. Dec 2001 B1
6336938 Kavteladze et al. Jan 2002 B1
6348065 Brown et al. Feb 2002 B1
6352552 Levinson et al. Mar 2002 B1
6355063 Calcote Mar 2002 B1
6361557 Gittings et al. Mar 2002 B1
6375676 Cox Apr 2002 B1
6375677 Penn et al. Apr 2002 B1
6380457 Yurek et al. Apr 2002 B1
6395020 Ley et al. May 2002 B1
6409750 Hyodoh et al. Jun 2002 B1
6409754 Smith et al. Jun 2002 B1
6416538 Ley et al. Jul 2002 B1
6420378 Rubinfeld Jul 2002 B1
6423084 St. Germain Jul 2002 B1
6423091 Hojeibane Jul 2002 B1
6423092 Datta et al. Jul 2002 B2
6428570 Globerman Aug 2002 B1
6432133 Lau et al. Aug 2002 B1
6436133 Furst et al. Aug 2002 B1
6440162 Cox et al. Aug 2002 B1
6443982 Israel et al. Sep 2002 B1
6451049 Vallana et al. Sep 2002 B2
6461380 Cox Oct 2002 B1
6461381 Israel et al. Oct 2002 B2
6464720 Boatman et al. Oct 2002 B2
6464722 Israel et al. Oct 2002 B2
6471721 Dang Oct 2002 B1
6475234 Richter et al. Nov 2002 B1
6475236 Roubin et al. Nov 2002 B1
6478815 Alt Nov 2002 B1
6488703 Kveen et al. Dec 2002 B1
6503556 Harish et al. Jan 2003 B2
6508834 Pinchasik et al. Jan 2003 B1
6514285 Pinchasik et al. Feb 2003 B1
6533805 Jervis Mar 2003 B1
6533810 Hankh et al. Mar 2003 B2
6540776 Sanders millare et al. Apr 2003 B2
6540777 Stenzel Apr 2003 B2
6551351 Smith et al. Apr 2003 B2
6569150 Teague et al. May 2003 B2
6569194 Pelton May 2003 B1
6572646 Boylan et al. Jun 2003 B1
6589276 Pinchasik et al. Jul 2003 B2
6602285 Von Oepen et al. Aug 2003 B1
6607551 Sullivan et al. Aug 2003 B1
6613078 Barone Sep 2003 B1
6613079 Wolinsky et al. Sep 2003 B1
6613080 Lootz Sep 2003 B1
6613081 Kim et al. Sep 2003 B2
6616688 Von Oepen Sep 2003 B2
6616689 Ainsworth et al. Sep 2003 B1
6616690 Rolando et al. Sep 2003 B2
6620192 Jalisi Sep 2003 B1
6620193 Lau et al. Sep 2003 B1
6620201 Nadal et al. Sep 2003 B1
6623518 Thompson et al. Sep 2003 B2
6623520 Jalisi Sep 2003 B2
6629994 Gomez et al. Oct 2003 B2
6635084 Israel et al. Oct 2003 B2
6638293 Makower et al. Oct 2003 B1
6638300 Frantzen Oct 2003 B1
6638302 Curcio et al. Oct 2003 B1
6641607 Hossainy et al. Nov 2003 B1
6641608 Pulnev Nov 2003 B1
6641609 Globerman Nov 2003 B2
6641611 Jayaraman Nov 2003 B2
6645240 Yec Nov 2003 B2
6645242 Quinn Nov 2003 B1
6652572 Kugler et al. Nov 2003 B2
6652573 Von Oepen Nov 2003 B2
6652575 Wang Nov 2003 B2
6652579 Cox et al. Nov 2003 B1
6653426 Alvarado et al. Nov 2003 B2
6656201 Ferrera et al. Dec 2003 B2
6656214 Fogarty et al. Dec 2003 B1
6656216 Hossainy et al. Dec 2003 B1
6656217 Herzog, Jr. et al. Dec 2003 B1
6656220 Gomez et al. Dec 2003 B1
6656351 Boyle Dec 2003 B2
6660019 Richter et al. Dec 2003 B1
6660030 Shaolian et al. Dec 2003 B2
6660034 Mandrusov et al. Dec 2003 B1
6660827 Loomis et al. Dec 2003 B2
6663664 Pacetti Dec 2003 B1
6664335 Krishnan Dec 2003 B2
6666881 Richter et al. Dec 2003 B1
6666884 Webster Dec 2003 B1
6669721 Bose et al. Dec 2003 B1
6669722 Chen et al. Dec 2003 B2
6669723 Killion et al. Dec 2003 B2
6673102 Vonesh et al. Jan 2004 B1
6673103 Golds et al. Jan 2004 B1
6673104 Barry Jan 2004 B2
6673105 Chen Jan 2004 B1
6673106 Mitelberg et al. Jan 2004 B2
6673107 Brandt et al. Jan 2004 B1
6673154 Pacetti et al. Jan 2004 B1
6676693 Belding et al. Jan 2004 B1
6676697 Richter Jan 2004 B1
6679910 Granada Jan 2004 B1
6679911 Burgermeister Jan 2004 B2
6682554 Oepen et al. Jan 2004 B2
6685736 White et al. Feb 2004 B1
6685745 Reever Feb 2004 B2
6689158 White et al. Feb 2004 B1
6689162 Thompson Feb 2004 B1
6692483 Vardi et al. Feb 2004 B2
6692521 Pinchasik Feb 2004 B2
6692522 Richter Feb 2004 B1
6695833 Frantzen Feb 2004 B1
6695876 Marotta et al. Feb 2004 B1
6699276 Sogard et al. Mar 2004 B2
6699278 Fischell et al. Mar 2004 B2
6702849 Dutta et al. Mar 2004 B1
6706061 Fischell et al. Mar 2004 B1
6706062 Vardi et al. Mar 2004 B2
6709440 Callol et al. Mar 2004 B2
6709451 Noble et al. Mar 2004 B1
6709453 Pinchasik et al. Mar 2004 B2
6709454 Cox et al. Mar 2004 B1
6712843 Elliott Mar 2004 B2
6712844 Pacetti Mar 2004 B2
6712846 Kraus et al. Mar 2004 B1
6716240 Fischell et al. Apr 2004 B2
6719782 Chuter Apr 2004 B1
6719991 Darouiche et al. Apr 2004 B2
6723118 Ballou et al. Apr 2004 B1
6723119 Pinchasik et al. Apr 2004 B2
6723120 Yan Apr 2004 B2
6723121 Zhong Apr 2004 B1
6723373 Narayanan et al. Apr 2004 B1
6730064 Ragheb et al. May 2004 B2
6730116 Wolinsky et al. May 2004 B1
6730117 Tseng et al. May 2004 B1
6730120 Berg et al. May 2004 B2
6733523 Shaolian et al. May 2004 B2
6733524 Tseng et al. May 2004 B2
6736838 Richter May 2004 B1
6736843 Fariabi May 2004 B1
6736844 Glatt et al. May 2004 B1
6740113 Vrba May 2004 B2
6740114 Burgermeister May 2004 B2
6740115 Lombardi et al. May 2004 B2
6743219 Dwyer et al. Jun 2004 B1
6743252 Bates et al. Jun 2004 B1
6746475 Rivelli, Jr. Jun 2004 B1
6746476 Hojeibane Jun 2004 B1
6746477 Moore Jun 2004 B2
6746479 Ehr et al. Jun 2004 B2
6746482 Ung-Chhun Jun 2004 B2
6749627 Thompson et al. Jun 2004 B2
6749629 Hong et al. Jun 2004 B1
6752819 Brady et al. Jun 2004 B1
6752826 Holloway et al. Jun 2004 B2
6752829 Kocur et al. Jun 2004 B2
6753071 Pacetti Jun 2004 B1
6755856 Fierens et al. Jun 2004 B2
6756007 Pletzer et al. Jun 2004 B2
6758858 McCrea et al. Jul 2004 B2
6758859 Dang et al. Jul 2004 B1
6758860 Penn et al. Jul 2004 B1
6761731 Majercak Jul 2004 B2
6764505 Hossainy et al. Jul 2004 B1
6764506 Roubin et al. Jul 2004 B2
6764507 Shanley et al. Jul 2004 B2
6764519 Whitmore, III Jul 2004 B2
6770086 Girton Aug 2004 B1
6770088 Jang Aug 2004 B1
6770089 Hong et al. Aug 2004 B1
6770091 Richter et al. Aug 2004 B2
6773445 Finlay et al. Aug 2004 B2
6773448 Kusleika et al. Aug 2004 B2
6774157 DelMain Aug 2004 B2
6774278 Ragheb et al. Aug 2004 B1
6776022 Kula et al. Aug 2004 B2
6776792 Yan et al. Aug 2004 B1
6776793 Brown et al. Aug 2004 B2
6776794 Hong et al. Aug 2004 B1
6776795 Pelton Aug 2004 B2
6776796 Falotico et al. Aug 2004 B2
6786918 Krivoruchko et al. Sep 2004 B1
6786929 Gambale et al. Sep 2004 B2
6790222 Kugler et al. Sep 2004 B2
6790227 Burgermeister Sep 2004 B2
6790228 Hossainy et al. Sep 2004 B2
6796997 Penn et al. Sep 2004 B1
6797217 McCrea et al. Sep 2004 B2
6800089 Wang Oct 2004 B1
6802846 Hauschild et al. Oct 2004 B2
6802859 Pazienza et al. Oct 2004 B1
6805702 Chen et al. Oct 2004 B1
6805703 McMorrow Oct 2004 B2
6805704 Hoyns Oct 2004 B1
6805705 Hong et al. Oct 2004 B2
6805706 Solovay et al. Oct 2004 B2
6805707 Hong et al. Oct 2004 B1
6805709 Schaldach et al. Oct 2004 B1
6805898 Wu et al. Oct 2004 B1
6808533 Goodwin et al. Oct 2004 B1
6814749 Cox et al. Nov 2004 B2
6818013 Mitelberg et al. Nov 2004 B2
6818014 Cox et al. Nov 2004 B2
6818015 Hankh et al. Nov 2004 B2
6818247 Chen et al. Nov 2004 B1
6821291 Bolea et al. Nov 2004 B2
6821292 Pazienza et al. Nov 2004 B2
6821293 Pinchasik Nov 2004 B2
6830638 Boylan et al. Dec 2004 B2
6833004 Ishii et al. Dec 2004 B2
6843802 Villalobos et al. Jan 2005 B1
6849086 Cragg Feb 2005 B2
6852123 Brown Feb 2005 B2
6852124 Cox et al. Feb 2005 B2
6858037 Penn et al. Feb 2005 B2
6860898 Stack et al. Mar 2005 B2
6860900 Clerc et al. Mar 2005 B2
6863684 Kim et al. Mar 2005 B2
6866805 Hong et al. Mar 2005 B2
6875227 Yoon Apr 2005 B2
6878162 Bales et al. Apr 2005 B2
6881221 Golds Apr 2005 B2
6881222 White et al. Apr 2005 B2
6881223 Penn et al. Apr 2005 B2
6887264 Penn et al. May 2005 B2
6896696 Doran et al. May 2005 B2
6896697 Yip et al. May 2005 B1
6896698 Rolando et al. May 2005 B2
6899727 Armstrong et al. May 2005 B2
6899729 Cox et al. May 2005 B1
6908624 Hossainy et al. Jun 2005 B2
6911039 Shiu et al. Jun 2005 B2
6911041 Zschecg Jun 2005 B1
6913617 Reiss Jul 2005 B1
6916336 Patel et al. Jul 2005 B2
6920677 Dolan et al. Jul 2005 B2
6942674 Belef et al. Sep 2005 B2
6953475 Shaolian et al. Oct 2005 B2
6955723 Pacetti et al. Oct 2005 B2
6972054 Kerrigan Dec 2005 B2
6979348 Sundar Dec 2005 B2
6981985 Brown et al. Jan 2006 B2
6984244 Perez et al. Jan 2006 B2
6989024 Herbert et al. Jan 2006 B2
7004966 Edwin et al. Feb 2006 B2
7011675 Hemerick et al. Mar 2006 B2
7547321 Roubin et al. Jun 2009 B2
20010000043 Israel et al. Mar 2001 A1
20010005793 Brenneman Jun 2001 A1
20010016767 Wilson et al. Aug 2001 A1
20010016768 Wilson et al. Aug 2001 A1
20010025195 Schaolian et al. Sep 2001 A1
20010027339 Boatman et al. Oct 2001 A1
20010037138 Wilston et al. Nov 2001 A1
20020002396 Fulkerson Jan 2002 A1
20020002399 Huxel et al. Jan 2002 A1
20020042650 Vardi et al. Apr 2002 A1
20020045933 Jang Apr 2002 A1
20020111672 Kim et al. Aug 2002 A1
20020156524 Ehr et al. Oct 2002 A1
20020178570 Sogard et al. Dec 2002 A1
20020183831 Rolando et al. Dec 2002 A1
20020183832 Penn et al. Dec 2002 A1
20020193866 Saunders Dec 2002 A1
20020198593 Gomez et al. Dec 2002 A1
20030004567 Boyle et al. Jan 2003 A1
20030024534 Silvestri et al. Feb 2003 A1
20030028240 Nolting et al. Feb 2003 A1
20030036793 Richter et al. Feb 2003 A1
20030040803 Rioux et al. Feb 2003 A1
20030045925 Jayaraman Mar 2003 A1
20030050690 Kveen et al. Mar 2003 A1
20030072868 Harish et al. Apr 2003 A1
20030074049 Hoganson et al. Apr 2003 A1
20030077310 Pathak et al. Apr 2003 A1
20030083734 Friedrich et al. May 2003 A1
20030105511 Welsh et al. Jun 2003 A1
20030105513 Moriuchi et al. Jun 2003 A1
20030114919 McQuiston et al. Jun 2003 A1
20030125799 Limon Jul 2003 A1
20030130611 Martin Jul 2003 A1
20030139796 Sequin et al. Jul 2003 A1
20030139803 Sequin et al. Jul 2003 A1
20030144726 Majercak et al. Jul 2003 A1
20030144731 Wolinsky et al. Jul 2003 A1
20030149469 Wolinsky et al. Aug 2003 A1
20030158596 Ikeuchi et al. Aug 2003 A1
20030208183 Whalen et al. Nov 2003 A1
20030212450 Schlick Nov 2003 A1
20030236567 Elliot Dec 2003 A1
20040059406 Cully et al. Mar 2004 A1
20040102834 Nakano et al. May 2004 A1
20040122511 Mangiardi et al. Jun 2004 A1
20040176833 Pavcnik et al. Sep 2004 A1
20040230119 Brustad et al. Nov 2004 A1
20040256769 Walter Dec 2004 A1
20050154448 Cully et al. Jul 2005 A1
20050192620 Cully et al. Sep 2005 A1
20050261183 Stewart et al. Nov 2005 A1
Foreign Referenced Citations (53)
Number Date Country
2356911 Jul 2000 CA
197 54 747 Jun 1999 DE
199 06 956 A 1 Aug 2000 DE
199 37 638 A 1 May 2001 DE
0 183 372 Oct 1984 EP
0 350 302 Jan 1990 EP
0 378 151 Jul 1990 EP
0 540 290 May 1993 EP
0 621 015 Oct 1994 EP
0 797 963 Jan 1997 EP
0 792 627 Mar 1997 EP
0 945 107 Jan 1999 EP
1036550 Sep 2000 EP
1 093 771 Apr 2001 EP
1088528 Apr 2001 EP
1 208 814 Sep 2001 EP
1151730 Nov 2001 EP
1197188 Apr 2002 EP
1 290 984 Dec 2003 EP
1 472 990 Nov 2004 EP
1550477 Jul 2005 EP
2758253 Jul 1998 FR
2002-102251 Apr 2002 JP
2002-345971 Dec 2002 JP
WO 9113384 Sep 1991 WO
WO 9211824 Jul 1992 WO
WO 9322986 Nov 1993 WO
WO 9404096 Mar 1994 WO
WO 9421196 Sep 1994 WO
WO 9707751 Mar 1997 WO
WO 9710011 Mar 1997 WO
WO 9732543 Mar 1997 WO
WO 9819628 May 1998 WO
WO 9902105 Jan 1999 WO
WO 9940876 Aug 1999 WO
WO 9962430 Dec 1999 WO
WO 0009041 Feb 2000 WO
WO 0044309 Aug 2000 WO
WO 0045742 Aug 2000 WO
WO 0166035 Sep 2001 WO
WO 0172239 Oct 2001 WO
WO 0176508 Oct 2001 WO
WO 0219948 Mar 2002 WO
WO 0224111 Mar 2002 WO
WO 0294132 Dec 2002 WO
WO 02100298 Dec 2002 WO
WO 03007781 Jan 2003 WO
WO 03018083 Mar 2003 WO
WO 03057075 Jul 2003 WO
WO 03065933 Aug 2003 WO
WO 03075797 Sep 2003 WO
WO 03082153 Oct 2003 WO
WO 2005011527 Feb 2005 WO
Related Publications (1)
Number Date Country
20040127974 A1 Jul 2004 US
Continuation in Parts (1)
Number Date Country
Parent 10288615 Nov 2002 US
Child 10718217 US